Drug Product

Move fast and move forward with WuXi AppTec Drug Product solutions.

Integrated formulation development, manufacturing, packaging, labeling, and clinical supply support from preclinical to commercial phase.

Drug Product Oligonucleotides Small Molecule

Start a Drug Product conversation Explore platform ↓

HERO IMAGE PLACEHOLDER Replace with Drug Product campaign image

1,500+Formulators & analytical scientists

1,000+Preclinical–Phase III molecules supported in 2024

10+Commercial products supported

Integrated support

Drug Product development built for momentum

We have a formulation R&D team of 1,500+ formulators & analytical scientists, providing formulation development and manufacturing from preclinical to commercial phase. Our integrated drug product R&D and manufacturing facilities around the world support both oral solid and parenteral dosage forms with various packaging formats.

Bioavailability enhancing technologies such as lipid nanoparticle and spray dried dispersion are also available from laboratory to production scale.

In 2024 alone, 1,000+ preclinical-phase III molecules were supported. Till now, 50+ late-phase NCEs were validated, and we supported 10+ commercial products.